Novo Nordisk Investigational Site

Berkeley, California 94704

0 studies enrolling now · 3 studies all time

What they study most

Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors

Studies at this site

• Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia — Completed
• Trial of NovoSeven® in Haemophilia - Joint Bleeds — Completed
• Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography — Completed